bazedoxifene has been researched along with Apoplexy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alborch, E; Aliena-Valero, A; Burguete, MC; Castelló-Ruiz, M; Centeno, JM; Jorques, M; Jover-Mengual, T; Jurado-Rodríguez, A; López-Morales, MA; Miranda, FJ; Pérez, S; Salom, JB; Torregrosa, G | 1 |
Liu, J; VAN Heertum, K | 1 |
Komm, BS; Mirkin, S; Thompson, JR | 1 |
de Villiers, TJ | 1 |
3 review(s) available for bazedoxifene and Apoplexy
Article | Year |
---|---|
Differential Effects of Progestogens Used for Menopausal Hormone Therapy.
Topics: Breast Neoplasms; Carbohydrate Metabolism; Cardiovascular Diseases; Carotid Intima-Media Thickness; Female; Hormone Replacement Therapy; Humans; Indoles; Lipids; Menopause; Progestins; Selective Estrogen Receptor Modulators; Stroke; Thromboembolism | 2018 |
Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials.
Topics: Coronary Disease; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Incidence; Indoles; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Venous Thromboembolism | 2015 |
Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women.
Topics: Cardiovascular Diseases; Female; Humans; Indoles; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Factors; Selective Estrogen Receptor Modulators; Stroke; Tamoxifen; Tetrahydronaphthalenes; Venous Thromboembolism | 2009 |
1 other study(ies) available for bazedoxifene and Apoplexy
Article | Year |
---|---|
Molecular mechanisms mediating the neuroprotective role of the selective estrogen receptor modulator, bazedoxifene, in acute ischemic stroke: A comparative study with 17β-estradiol.
Topics: Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Indoles; Male; MAP Kinase Signaling System; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Phosphatidylinositol Phosphates; Rats, Wistar; Receptors, G-Protein-Coupled; Reperfusion Injury; Second Messenger Systems; Selective Estrogen Receptor Modulators; Stroke | 2017 |